Seegene, Inc. (KOSDAQ:096530)

South Korea · Delayed Price · Currency is KRW

30,450

+2,450 (8.75%)

Jun 29, 2026, 3:30 PM KST

-7.73% (1Y)

Market Cap	1.40T -9.1%
Revenue (ttm)	487.37B +10.7%
Net Income	65.66B +515.9%
EPS	1,425.64 +517.4%
Shares Out	46.11M
PE Ratio	21.36
Forward PE	16.53
Dividend	800.00 (2.86%)
Ex-Dividend Date	Jun 29, 2026

Volume	409,044
Open	28,000
Previous Close	28,000
Day's Range	28,000 - 30,500
52-Week Range	21,700 - 35,350
Beta	0.89
Analysts	Buy
Price Target	39,500.00 (+29.72%)
Earnings Date	Aug 7, 2026

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de... [Read more]

Industry Medical - Specialties

Sector Healthcare

Founded 2000

Employees 216

Stock Exchange KOSDAQ

Ticker Symbol 096530

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 096530 stock is "Buy." The 12-month stock price target is ₩39,500, which is an increase of 29.72% from the latest price.

Price Target

₩39,500

(29.72% upside)

Analyst Consensus: Buy

Stock Forecasts